Chemoinformaics analysis of beta-Hydroxypropiovanillone
| Molecular Weight | 196.202 | nRot | 4 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 7 |
| Exact Molecular Weight | 196.074 | nRing | 1 |
| Solubility: LogS | -1.371 | nHRing | 0 |
| Solubility: LogP | 0.571 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 27.9095 |
| nHD | 2 | BPOL | 14.6425 |
| QED | 0.704 |
| Synth | 1.908 |
| Natural Product Likeliness | 0.699 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.008 |
| HIA | 0.022 |
| CACO-2 | -4.457 |
| MDCK | 0.0000143 |
| BBB | 0.736 |
| PPB | 0.36284 |
| VDSS | 0.947 |
| FU | 0.651778 |
| CYP1A2-inh | 0.415 |
| CYP1A2-sub | 0.756 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.633 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.488 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.251 |
| CL | 10.052 |
| T12 | 0.917 |
| hERG | 0.027 |
| Ames | 0.118 |
| ROA | 0.035 |
| SkinSen | 0.238 |
| Carcinogencity | 0.218 |
| EI | 0.964 |
| Respiratory | 0.123 |
| NR-Aromatase | 0.05 |
| Antiviral | No |
| Prediction | 0.864142 |